Annual D&A
$815.00 K
+$141.00 K+20.92%
31 December 2023
Summary:
Keros Therapeutics annual depreciation & amortization is currently $815.00 thousand, with the most recent change of +$141.00 thousand (+20.92%) on 31 December 2023. During the last 3 years, it has risen by +$537.00 thousand (+193.17%). KROS annual D&A is now at all-time high.KROS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$314.00 K
+$8000.00+2.61%
30 September 2024
Summary:
Keros Therapeutics quarterly depreciation & amortization is currently $314.00 thousand, with the most recent change of +$8000.00 (+2.61%) on 30 September 2024. Over the past year, it has increased by +$104.00 thousand (+49.52%). KROS quarterly D&A is now at all-time high.KROS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$1.14 M
+$104.00 K+10.00%
30 September 2024
Summary:
Keros Therapeutics TTM depreciation & amortization is currently $1.14 million, with the most recent change of +$104.00 thousand (+10.00%) on 30 September 2024. Over the past year, it has increased by +$449.00 thousand (+64.60%). KROS TTM D&A is now at all-time high.KROS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KROS Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.9% | +49.5% | +64.6% |
| 3 y3 years | +193.2% | +204.8% | +227.8% |
| 5 y5 years | +432.7% | +470.9% | +667.8% |
KROS Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +193.2% | at high | +204.8% | at high | +227.8% |
| 5 y | 5 years | at high | +432.7% | at high | +470.9% | at high | +667.8% |
| alltime | all time | at high | +432.7% | at high | +597.8% | at high | +2442.2% |
Keros Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $314.00 K(+2.6%) | $1.14 M(+10.0%) |
| June 2024 | - | $306.00 K(+10.5%) | $1.04 M(+12.4%) |
| Mar 2024 | - | $277.00 K(+12.1%) | $925.00 K(+13.5%) |
| Dec 2023 | $815.00 K(+20.9%) | $247.00 K(+17.6%) | $815.00 K(+17.3%) |
| Sept 2023 | - | $210.00 K(+9.9%) | $695.00 K(+13.7%) |
| June 2023 | - | $191.00 K(+14.4%) | $611.00 K(-16.1%) |
| Mar 2023 | - | $167.00 K(+31.5%) | $728.00 K(+8.0%) |
| Dec 2022 | $674.00 K(+78.3%) | $127.00 K(+0.8%) | $674.00 K(+3.5%) |
| Sept 2022 | - | $126.00 K(-59.1%) | $651.00 K(+3.7%) |
| June 2022 | - | $308.00 K(+172.6%) | $628.00 K(+52.8%) |
| Mar 2022 | - | $113.00 K(+8.7%) | $411.00 K(+8.7%) |
| Dec 2021 | $378.00 K | $104.00 K(+1.0%) | $378.00 K(+8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $103.00 K(+13.2%) | $349.00 K(+9.7%) |
| June 2021 | - | $91.00 K(+13.8%) | $318.00 K(+7.8%) |
| Mar 2021 | - | $80.00 K(+6.7%) | $295.00 K(+6.1%) |
| Dec 2020 | $278.00 K(+33.7%) | $75.00 K(+4.2%) | $278.00 K(+6.1%) |
| Sept 2020 | - | $72.00 K(+5.9%) | $262.00 K(+6.9%) |
| June 2020 | - | $68.00 K(+7.9%) | $245.00 K(+8.4%) |
| Mar 2020 | - | $63.00 K(+6.8%) | $226.00 K(+8.7%) |
| Dec 2019 | $208.00 K(+35.9%) | $59.00 K(+7.3%) | $208.00 K(+39.6%) |
| Sept 2019 | - | $55.00 K(+12.2%) | $149.00 K(+58.5%) |
| June 2019 | - | $49.00 K(+8.9%) | $94.00 K(+108.9%) |
| Mar 2019 | - | $45.00 K | $45.00 K |
| Dec 2018 | $153.00 K | - | - |
FAQ
- What is Keros Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Keros Therapeutics?
- What is Keros Therapeutics annual D&A year-on-year change?
- What is Keros Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Keros Therapeutics?
- What is Keros Therapeutics quarterly D&A year-on-year change?
- What is Keros Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Keros Therapeutics?
- What is Keros Therapeutics TTM D&A year-on-year change?
What is Keros Therapeutics annual depreciation & amortization?
The current annual D&A of KROS is $815.00 K
What is the all time high annual D&A for Keros Therapeutics?
Keros Therapeutics all-time high annual depreciation & amortization is $815.00 K
What is Keros Therapeutics annual D&A year-on-year change?
Over the past year, KROS annual depreciation & amortization has changed by +$141.00 K (+20.92%)
What is Keros Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of KROS is $314.00 K
What is the all time high quarterly D&A for Keros Therapeutics?
Keros Therapeutics all-time high quarterly depreciation & amortization is $314.00 K
What is Keros Therapeutics quarterly D&A year-on-year change?
Over the past year, KROS quarterly depreciation & amortization has changed by +$104.00 K (+49.52%)
What is Keros Therapeutics TTM depreciation & amortization?
The current TTM D&A of KROS is $1.14 M
What is the all time high TTM D&A for Keros Therapeutics?
Keros Therapeutics all-time high TTM depreciation & amortization is $1.14 M
What is Keros Therapeutics TTM D&A year-on-year change?
Over the past year, KROS TTM depreciation & amortization has changed by +$449.00 K (+64.60%)